Communiqués EBOS Group Limited

Actions

Cours en clôture New Zealand S.E. 09/10/2026			Varia. 5j.	Varia. 1 janv.
18,98 ^NZD	+0,74%		-1,25%	-31,28%

09/09	EBOS Group fixe le prix d'exercice des actions dans le cadre de son plan de réinvestissement des dividendes	MT
19/08	EBOS Group Limited annonce un dividende final pour l'exercice 2026, payable le 18 septembre 2026	CI

06/05	EBOS : Investor Day Presentation	PU
24/02	EBOS : 2026 Interim Report	PU
24/02	EBOS : Interim Shareholders Report 2026	PU
24/02	Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect	AQ
27/08/25	EBOS : 2025 Full Year Results Investor Presentation	PU
19/02/25	EBOS : 2025 Half Year Results Investor Presentation	PU
18/02/25	EBOS : 2025 Interim Report	PU
22/08/24	Morgans rates EBO as Add	AQ
21/08/24	EBOS : 2024 Full Year Results Investor Presentation	PU
22/02/24	Ord Minnett rates EBO as Lighten	AQ
23/11/23	Ord Minnett rates EBO as Lighten	AQ
07/06/23	Morgans rates EBO as Add	AQ
23/02/23	Morgans rates EBO as Add	AQ
23/08/22	EBOS : 2022 Sustainability Report	PU
25/07/22	EBOS : Application for quotation of securities - EBO	PU
20/06/22	EBOS : Application for quotation of securities - EBO	PU
31/05/22	EBOS : Appendix 2A	PU
19/04/22	EBOS : Application for quotation of securities - EBO	PU
31/03/22	EBOS : Correction to ASX Appendix 2A	PU
24/03/22	EBOS' proposed acquisition of Pacific Health Group not opposed	AQ
16/03/22	EBOS : Application for quotation of securities - EBO	PU
23/02/22	EBOS : Notification regarding unquoted securities - EBO	PU
18/02/22	EBOS : Application for quotation of securities - EBO	PU
15/02/22	EBOS : Interim Report	PU
15/02/22	EBOS : ASX Appendix 4D	PU